T
Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
Tsukasa Nakamura's research focuses on organ transplantation, particularly kidney and liver transplants, and the factors influencing their outcomes. Recent work includes studies on xenotransplantation of porcine kidneys for end-stage kidney disease and the impact of portable normothermic machine perfusion for liver transplantation. Nakamura has also investigated the effects of donor and recipient age on liver transplant outcomes and explored the relationship between systolic blood pressure targets and kidney function decline in chronic kidney disease patients.
Additional areas of investigation include the impact of zinc acetate hydrate supplementation on renal anemia in hemodialysis patients and the treatment of unresectable hepatocellular carcinoma. Nakamura's scholarship metrics indicate a significant body of work, with 440 publications and a citation count of 8,073, contributing to a designation as a highly cited researcher. Collaborations include work with Martha Estrada, Martha M Estrada, Lyle Burdine, and John R. Montgomery at the University of Arkansas for Medical Sciences.
Metrics
- h-index: 46
- Publications: 438
- Citations: 8,128
Selected Publications
-
Examining Differential Transplantation Rates and Outcomes by Center Volume During Weekend and Holidays (2025)
-
Innovations to Expand the Liver Donor Pool (2025)
Collaboration Network
Top Collaborators
Takeshi Morimoto
Hyogo Medical University (JP)
11 shared publications
- Experience and awareness of research integrity among Japanese physicians: a nationwide cross-sectional study
- Effectiveness of a computerized clinical decision support system for prevention of glucocorticoid-induced osteoporosis
- Clinical characteristics and factors related to antibiotic-associated diarrhea in elderly patients with pneumonia: a retrospective cohort study
- Monitoring for adverse drug events of high-risk medications with a computerized clinical decision support system: a prospective cohort study
- Low Serum Total Protein at Admission Predicts in-Hospital Mortality Among General Inpatients: Historical Cohort Study
Showing 5 of 11 shared publications
Daisuke Kihara
Purdue University West Lafayette (US)
9 shared publications
- Integrated Protocol of Protein Structure Modeling for Cryo-EM with Deep Learning and Structure Prediction
- Structure Modeling Protocols for Protein Multimer and <scp>RNA</scp> in <scp>CASP16</scp> With Enhanced <scp>MSAs</scp> , Model Ranking, and Deep Learning
- DAQ-score database: Deep-learning based quality estimation of cryo-EM derived protein models
- Quality assessment and biomolecular structure modeling for cryo-EM using deep learning
- DeepMainmast and cryoREAD: Protein and DNA/RNA structure modeling for cryo-EM using deep learning
Showing 5 of 9 shared publications
Genki Terashi
Purdue University West Lafayette (US)
7 shared publications
- Integrated Protocol of Protein Structure Modeling for Cryo-EM with Deep Learning and Structure Prediction
- Structure Modeling Protocols for Protein Multimer and <scp>RNA</scp> in <scp>CASP16</scp> With Enhanced <scp>MSAs</scp> , Model Ranking, and Deep Learning
- DAQ-score database: Deep-learning based quality estimation of cryo-EM derived protein models
- Quality assessment and biomolecular structure modeling for cryo-EM using deep learning
- DeepMainmast and cryoREAD: Protein and DNA/RNA structure modeling for cryo-EM using deep learning
Showing 5 of 7 shared publications
Mio Sakuma
Hyogo University (JP)
6 shared publications
- Experience and awareness of research integrity among Japanese physicians: a nationwide cross-sectional study
- Effectiveness of a computerized clinical decision support system for prevention of glucocorticoid-induced osteoporosis
- Monitoring for adverse drug events of high-risk medications with a computerized clinical decision support system: a prospective cohort study
- Low Serum Total Protein at Admission Predicts in-Hospital Mortality Among General Inpatients: Historical Cohort Study
- Rationale and protocol for a prospective cohort study of respiratory viral infections in patients admitted from emergency departments of community hospitals: Effect of respiratory Virus infection on EmeRgencY admission (EVERY) study
Showing 5 of 6 shared publications
James F. Markmann
Penn Center for AIDS Research (US)
6 shared publications
- Impact of Portable Normothermic Machine Perfusion for Liver Transplantation From Adult Deceased Donors
- Role of Machine Perfusion in Liver Transplantation
- Impact of donor sex on hepatocellular carcinoma recurrence in liver transplantation after brain death
- Two‐day Static Cold Preservation of α1,3‐Galactosyltransferase Knockout Kidney Grafts Before Simulated Xenotransplantation
- Innovations to Expand the Liver Donor Pool
Showing 5 of 6 shared publications
Jiro Takeuchi
Hyogo University (JP)
5 shared publications
- Experience and awareness of research integrity among Japanese physicians: a nationwide cross-sectional study
- Effectiveness of a computerized clinical decision support system for prevention of glucocorticoid-induced osteoporosis
- Monitoring for adverse drug events of high-risk medications with a computerized clinical decision support system: a prospective cohort study
- Low Serum Total Protein at Admission Predicts in-Hospital Mortality Among General Inpatients: Historical Cohort Study
- Proactive Learning Program on Research Integrity in Clinical Research Training
Shoko Kimura
Harvard University (US)
5 shared publications
- Xenotransplantation of a Porcine Kidney for End-Stage Kidney Disease
- Impact of Portable Normothermic Machine Perfusion for Liver Transplantation From Adult Deceased Donors
- Impact of donor sex on hepatocellular carcinoma recurrence in liver transplantation after brain death
- Two‐day Static Cold Preservation of α1,3‐Galactosyltransferase Knockout Kidney Grafts Before Simulated Xenotransplantation
- Rapidly Progressive Pulmonary Lymphangitic Carcinomatosis After Liver Transplantation Due to Diffuse Infiltrative Sarcomatoid Hepatocellular Carcinoma
Alban Longchamp
Harvard University (US)
5 shared publications
- Xenotransplantation of a Porcine Kidney for End-Stage Kidney Disease
- Role of Machine Perfusion in Liver Transplantation
- Two‐day Static Cold Preservation of α1,3‐Galactosyltransferase Knockout Kidney Grafts Before Simulated Xenotransplantation
- Innovations to Expand the Liver Donor Pool
- Build a kidney transplant trainer in 30 min without leaving the hospital
Rie Sugimoto
National Hospital Organization Kyushu Cancer Center (JP)
4 shared publications
- Atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma progressing after molecular targeted therapy: A multicenter prospective observational study
- Factors Contributing to the Prognosis after Second-line Therapy with Ramucirumab in Advanced Hepatocellular Carcinoma
- Atezolizumab plus bevacizumab treatment worsens liver reserve in patients with NAFLD/NASH-associated liver cancer more than in those with non-NAFLD/non-NASH-associated liver cancer
- Initial experience with the combination of atezolizumab and bevacizumab in patients with unresectable hepatocellular carcinoma progressing after tyrosine kinase inhibitor therapy: A multicenter prospective observational study
Takeaki Satoh
4 shared publications
- Atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma progressing after molecular targeted therapy: A multicenter prospective observational study
- Factors Contributing to the Prognosis after Second-line Therapy with Ramucirumab in Advanced Hepatocellular Carcinoma
- Atezolizumab plus bevacizumab treatment worsens liver reserve in patients with NAFLD/NASH-associated liver cancer more than in those with non-NAFLD/non-NASH-associated liver cancer
- Initial experience with the combination of atezolizumab and bevacizumab in patients with unresectable hepatocellular carcinoma progressing after tyrosine kinase inhibitor therapy: A multicenter prospective observational study
Takeshi Senju
Kyushu Rosai Hospital (JP)
4 shared publications
- Atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma progressing after molecular targeted therapy: A multicenter prospective observational study
- Factors Contributing to the Prognosis after Second-line Therapy with Ramucirumab in Advanced Hepatocellular Carcinoma
- Atezolizumab plus bevacizumab treatment worsens liver reserve in patients with NAFLD/NASH-associated liver cancer more than in those with non-NAFLD/non-NASH-associated liver cancer
- Initial experience with the combination of atezolizumab and bevacizumab in patients with unresectable hepatocellular carcinoma progressing after tyrosine kinase inhibitor therapy: A multicenter prospective observational study
Toshimasa Koyanagi
Fukuoka City Hospital (JP)
4 shared publications
- Atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma progressing after molecular targeted therapy: A multicenter prospective observational study
- Factors Contributing to the Prognosis after Second-line Therapy with Ramucirumab in Advanced Hepatocellular Carcinoma
- Atezolizumab plus bevacizumab treatment worsens liver reserve in patients with NAFLD/NASH-associated liver cancer more than in those with non-NAFLD/non-NASH-associated liver cancer
- Initial experience with the combination of atezolizumab and bevacizumab in patients with unresectable hepatocellular carcinoma progressing after tyrosine kinase inhibitor therapy: A multicenter prospective observational study
Nobito Higuchi
Fukuoka City Hospital (JP)
4 shared publications
- Atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma progressing after molecular targeted therapy: A multicenter prospective observational study
- Factors Contributing to the Prognosis after Second-line Therapy with Ramucirumab in Advanced Hepatocellular Carcinoma
- Atezolizumab plus bevacizumab treatment worsens liver reserve in patients with NAFLD/NASH-associated liver cancer more than in those with non-NAFLD/non-NASH-associated liver cancer
- Initial experience with the combination of atezolizumab and bevacizumab in patients with unresectable hepatocellular carcinoma progressing after tyrosine kinase inhibitor therapy: A multicenter prospective observational study
Masatake Tanaka
Kyushu University (JP)
4 shared publications
- Atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma progressing after molecular targeted therapy: A multicenter prospective observational study
- Factors Contributing to the Prognosis after Second-line Therapy with Ramucirumab in Advanced Hepatocellular Carcinoma
- Atezolizumab plus bevacizumab treatment worsens liver reserve in patients with NAFLD/NASH-associated liver cancer more than in those with non-NAFLD/non-NASH-associated liver cancer
- Initial experience with the combination of atezolizumab and bevacizumab in patients with unresectable hepatocellular carcinoma progressing after tyrosine kinase inhibitor therapy: A multicenter prospective observational study
Aritsune Ooho
Nippon Steel Yawata Memorial Hospital (JP)
4 shared publications
- Atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma progressing after molecular targeted therapy: A multicenter prospective observational study
- Factors Contributing to the Prognosis after Second-line Therapy with Ramucirumab in Advanced Hepatocellular Carcinoma
- Atezolizumab plus bevacizumab treatment worsens liver reserve in patients with NAFLD/NASH-associated liver cancer more than in those with non-NAFLD/non-NASH-associated liver cancer
- Initial experience with the combination of atezolizumab and bevacizumab in patients with unresectable hepatocellular carcinoma progressing after tyrosine kinase inhibitor therapy: A multicenter prospective observational study
Similar Researchers
Based on overlapping research topics
Teresa Fletchinger
University of Arkansas for Medical Sciences
Organ Transplantation Techniques and Outcomes
Dialysis and Renal Disease Management
Health Disparities and Outcomes
Mauricio Garcia Saenz de Sicilia
University of Arkansas for Medical Sciences
Organ Transplantation Techniques and Outcomes
Metabolism and Genetic Disorders
Health Disparities and Outcomes
Ajay K. Israni
University of Arkansas for Medical Sciences
Organ Transplantation Techniques and Outcomes
Dialysis and Renal Disease Management
Health Disparities and Outcomes
Kristin Kampevold Larsen
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Metabolism and Genetic Disorders
Health Disparities and Outcomes
Venkata Manchala
University of Arkansas for Medical Sciences
Organ Transplantation Techniques and Outcomes
Dialysis and Renal Disease Management
Metabolism and Genetic Disorders
Kathleen Danielle Aldrich
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Metabolism and Genetic Disorders
Health Disparities and Outcomes